Dieter Vanderschaeghe
Papers
1
Total Citations
17
H-Index
1
About
Dieter Vanderschaeghe is a leading researcher in clinical glycomics, with a focus on the role of protein glycosylation in chronic inflammatory and autoimmune diseases. His major contribution lies in the development of a groundbreaking, simplified clinical chemistry procedure using Endoglycosidase S to directly assess serum IgG undergalactosylation—a hallmark of conditions such as rheumatoid arthritis, Crohn’s disease, lupus, and steatohepatitis (ASH/NASH). This work, published in 2018, has garnered 17 citations and represents a significant leap toward routine diagnostic application, replacing complex, multi-step methods with a streamlined assay. Vanderschaeghe’s research bridges fundamental glycobiology and translational medicine, offering a practical tool for monitoring disease activity and progression. His achievements include advancing the understanding of how altered IgG glycosylation drives inflammation, and his work has been recognized for its potential to transform clinical diagnostics. For students and researchers, his contributions exemplify how innovative biochemical techniques can directly impact patient care, making him a key figure in the field of glycobiology and chronic disease research.
Research Focus
Key Achievements
Top Papers
- 1